Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging
Aaron R. Jeffries(University of Exeter), Emma L. Baple(University of Exeter), Deborah Mackay(University of Copenhagen), Vinod Varghese(University Hospital of Wales), Diana Baralle(Princess Anne Hospital), Andrew H. Crosby(University of Exeter), Faisal I. Rezwan(University of Cambridge), Angelo Selicorni(Fondazione Roma), Jonathan Mill(University of Exeter), Lionel Van Maldergem, Naomi Yachelevich(New York City Health and Hospitals Corporation), Ajith Kumar(Great Ormond Street Hospital), Matthew F. Hunter(The University of Sydney), Harold E. Cross(University of Arizona), Lise Aksglæde(Copenhagen University Hospital), Ruth Newbury‐Ecob(University Hospitals Bristol NHS Foundation Trust), Amanda Springer(Monash Health), Barry A. Chioza(University of Exeter), Claire Salter(Birmingham Women’s and Children’s NHS Foundation Trust), Katrina Tatton‐Brown(St George’s University Hospitals NHS Foundation Trust), Reza Maroofian(University College London), Michael A. Patton(St George's Hospital), Arveen Kamath(University Hospital of Wales), Tabib Dabir(Belfast Health and Social Care Trust), I. Karen Temple(University of Southampton)
Cited by 10
Related Papers
Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene
|Science|2003|8.1k
Role of Genotype in the Cycle of Violence in Maltreated Children
|Science|2002|4.8k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766